Premium
Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co‐infection
Author(s) -
RodríguezFramil M.,
Antela A.,
Prieto A.,
Otero E.,
Molina E.,
Varo E.
Publication year - 2011
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2011.00620.x
Subject(s) - medicine , pyrazinamide , ethambutol , liver transplantation , tuberculosis , isoniazid , moxifloxacin , liver abscess , hepatitis , virology , transplantation , immunology , abscess , pathology , antibiotics , surgery , microbiology and biotechnology , biology
M. Rodríguez‐Framil, A. Antela, A. Prieto, E. Otero, E. Molina, E. Varo. Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co‐infection.
Transpl Infect Dis 2011: 13: 515–519. All rights reserved Abstract: Tuberculosis infection occurs relatively frequently in solid organ transplant recipients, although the occurrence of tuberculous hepatic abscesses is uncommon. Anti‐tuberculous therapy has several concerns in transplant recipients, including an increased risk of cellular rejection and potential hepatotoxicity. We present the case of a human immunodeficiency virus‐infected liver transplant patient who developed multiple tuberculous liver abscesses. Treatment with isoniazid, ethambutol, pyrazinamide, and moxifloxacin was efficacious, well tolerated, and safe.